• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与乳腺癌脑转移患者生存相关的临床病理因素。

Clinicopathological factors associated with survival in patients with breast cancer brain metastasis.

作者信息

Li Rong, Zhang Kui, Siegal Gene P, Wei Shi

机构信息

Department of Pathology, the University of Alabama at Birmingham, Birmingham, AL 35249, USA.

Department of Mathematical Sciences, Michigan Technological University, Houghton, MI 49931, USA.

出版信息

Hum Pathol. 2017 Jun;64:53-60. doi: 10.1016/j.humpath.2017.03.022. Epub 2017 Apr 17.

DOI:10.1016/j.humpath.2017.03.022
PMID:28428107
Abstract

Brain metastasis from breast cancer generally represents a catastrophic event yet demonstrates substantial biological heterogeneity. There have been limited studies solely focusing on the prognosis of patients with such metastasis. In this study, we carried out a comprehensive analysis in 108 consecutive patients with breast cancer brain metastases between 1997 and 2012 to further define clinicopathological factors associated with early onset of brain metastasis and survival outcomes after development of them. We found that lobular carcinoma, higher clinical stages at diagnosis, and lack of coexisting bone metastasis were significantly associated with a worse brain relapse-free survival when compared with brain-only metastasis. High histologic grade, triple-negative breast cancer, and absence of visceral involvement were unfavorable prognostic factors after brain metastasis. Furthermore, high histologic grade, advanced tumor stages, and lack of coexisting bone involvement indicated a worse overall survival. Thus, the previously established prognostic factors in early stage or advanced breast cancers may not entirely apply to patients with brain metastases. Furthermore, the prognostic significance of the clinicopathological factors differed before and after a patient develops brain metastasis. This knowledge might help in establishing an algorithm to further stratify patients with breast cancer into prognostically significant categories for optimal prevention, screening, and treatment of their brain metastasis.

摘要

乳腺癌脑转移通常是一个灾难性事件,但具有显著的生物学异质性。仅专注于此类转移患者预后的研究有限。在本研究中,我们对1997年至2012年间连续的108例乳腺癌脑转移患者进行了全面分析,以进一步确定与脑转移早期发生及发生后生存结果相关的临床病理因素。我们发现,与单纯脑转移相比,小叶癌、诊断时较高的临床分期以及不存在并存骨转移与较差的无脑复发生存率显著相关。高组织学分级、三阴性乳腺癌以及不存在内脏受累是脑转移后的不良预后因素。此外,高组织学分级、晚期肿瘤分期以及不存在并存骨受累提示总体生存率较差。因此,先前在早期或晚期乳腺癌中确立的预后因素可能并不完全适用于脑转移患者。此外,临床病理因素的预后意义在患者发生脑转移前后有所不同。这一认识可能有助于建立一种算法,将乳腺癌患者进一步分层为具有预后意义的类别,以实现对其脑转移的最佳预防、筛查和治疗。

相似文献

1
Clinicopathological factors associated with survival in patients with breast cancer brain metastasis.与乳腺癌脑转移患者生存相关的临床病理因素。
Hum Pathol. 2017 Jun;64:53-60. doi: 10.1016/j.humpath.2017.03.022. Epub 2017 Apr 17.
2
Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationship.乳腺癌的诊断年龄与远处转移——出人意料的反比关系。
Eur J Cancer. 2014 Jul;50(10):1697-1705. doi: 10.1016/j.ejca.2014.04.002. Epub 2014 Apr 23.
3
Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.基于临床病理因素和基因表达分析预测晚期HER2阳性乳腺癌患者早期脑转移
J Neurooncol. 2015 Mar;122(1):205-16. doi: 10.1007/s11060-014-1704-y. Epub 2015 Jan 6.
4
Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis.核因子κ B 受体激活剂的表达预测乳腺癌伴骨转移患者预后不良,但不预测伴内脏转移患者的预后不良。
J Clin Pathol. 2012 Jan;65(1):36-40. doi: 10.1136/jclinpath-2011-200312. Epub 2011 Nov 2.
5
BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma.BAG-1/SODD、热休克蛋白70(HSP70)和热休克蛋白90(HSP90)是淋巴结阴性乳腺癌患者生存预后不良的潜在标志物。
Hum Pathol. 2016 Aug;54:64-73. doi: 10.1016/j.humpath.2016.02.023. Epub 2016 Mar 30.
6
Factors affecting survival in breast cancer patients following bone metastasis.影响乳腺癌骨转移患者生存的因素。
Tumori. 2007 Nov-Dec;93(6):580-6. doi: 10.1177/030089160709300611.
7
Prognostic Markers and Histologic Subtypes in Patients with Meningeal Carcinomatosis in Breast Cancer.乳腺癌脑膜癌病患者的预后标志物与组织学亚型
Acta Cytol. 2017;61(2):140-144. doi: 10.1159/000455115. Epub 2017 Feb 24.
8
Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas.骨形态发生蛋白7的表达与乳腺癌骨转移相关。
Ann Oncol. 2008 Feb;19(2):308-14. doi: 10.1093/annonc/mdm453. Epub 2007 Sep 24.
9
Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.SIRT1与Notch1信号通路在乳腺癌中的相关性及预后价值
J Exp Clin Cancer Res. 2014 Nov 25;33(1):97. doi: 10.1186/s13046-014-0097-2.
10
Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important.晚期乳腺癌的预后结果:无转移间期很重要。
Hum Pathol. 2017 Dec;70:70-76. doi: 10.1016/j.humpath.2017.10.002. Epub 2017 Oct 13.

引用本文的文献

1
Investigation of Prevalence, Survival, and Molecular Type of Breast Cancer Patients with Brain Metastases.脑转移乳腺癌患者的患病率、生存率及分子类型研究。
Adv Biomed Res. 2025 Mar 28;14:26. doi: 10.4103/abr.abr_262_24. eCollection 2025.
2
Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas.建立预测模型并揭示免疫因素对肺癌脑转移预后的影响。
Front Oncol. 2025 Mar 3;15:1554242. doi: 10.3389/fonc.2025.1554242. eCollection 2025.
3
Clinico-pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis.
初诊脑转移乳腺癌患者的临床病理因素与生存:国家癌症数据库分析。
Breast Cancer Res Treat. 2024 Aug;206(3):527-541. doi: 10.1007/s10549-024-07321-x. Epub 2024 Apr 29.
4
LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis.LINC00460 通过 miR-320a/MAL2 轴促进乳腺癌细胞增殖并抑制铁死亡。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231164359. doi: 10.1177/15330338231164359.
5
Prognosis of lung cancer with simple brain metastasis patients and establishment of survival prediction models: a study based on real events.单纯性脑转移肺癌患者的预后及生存预测模型的建立:基于真实事件的研究。
BMC Pulm Med. 2022 Apr 27;22(1):162. doi: 10.1186/s12890-022-01936-w.
6
The effect of metastasis patterns on survival in male patients with different breast cancer subtypes: results from the Surveillance, Epidemiology, and End Results (SEER) database.转移模式对不同乳腺癌亚型男性患者生存的影响:来自监测、流行病学和最终结果(SEER)数据库的结果
Transl Cancer Res. 2020 Apr;9(4):2267-2279. doi: 10.21037/tcr.2020.03.43.
7
A view on the landscape of breast cancer brain metastases.关于乳腺癌脑转移的全景观察。
CNS Oncol. 2020 Sep 1;9(3):CNS59. doi: 10.2217/cns-2020-0013. Epub 2020 Sep 29.
8
Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer.影响乳腺癌无脑转移生存期及脑转移后生存期的预后因素分析
Front Oncol. 2020 Apr 3;10:431. doi: 10.3389/fonc.2020.00431. eCollection 2020.
9
Risk factors for breast cancer brain metastases: a systematic review.乳腺癌脑转移的危险因素:一项系统综述。
Oncotarget. 2020 Feb 11;11(6):650-669. doi: 10.18632/oncotarget.27453.
10
Investigation of Prognostic Factors of Survival in Breast Cancer Using a Frailty Model: A Multicenter Study.使用脆弱模型研究乳腺癌生存的预后因素:一项多中心研究
Breast Cancer (Auckl). 2019 Sep 29;13:1178223419879112. doi: 10.1177/1178223419879112. eCollection 2019.